1. Search Result
Search Result
Results for "

Cd22 Inhibitors

" in MCE Product Catalog:

4

Inhibitors & Agonists

3

Inhibitory Antibodies

16

Recombinant Proteins

Cat. No. Product Name Target Research Areas
  • HY-146081
    CD22 ligand-1

    Others Cancer
    CD22 ligand-1 (compound 12) is a potent and selective CD22 ligand with KD of 0.335, 30.7 µM for hCD22 and MAG, respectively. CD22 ligand-1 has the potential for the research of B-cell related disease.
  • HY-P99230
    Pinatuzumab

    Integrin Cancer
    Pinatuzumab is a CD22 monoclonal antibody. Pinatuzumab targets the cell-surface antigen CD22. Pinatuzumab can be used for synthesis of antibody drug conjugates (ADCs) to research several diseases including non-Hodgkin lymphoma (NHL).
  • HY-132250
    MCC-DM1

    Drug-Linker Conjugates for ADC Cancer
    MCC-DM1 is a drug-Linker Conjugates for ADC such ad Anti-CD22-MCC-DM1.
  • HY-112099
    Mc-Val-Cit-PAB-Cl

    ADC Linker Cancer
    Mc-Val-Cit-PAB-Cl is a cleavable ADC linker. Mc-Val-Cit-PAB-Cl can be used to conjugate MMAE and antibody to form antibody-MC-vc-MMAE (e.g., anti-CD22-MC-VC-PABC-MMAE with IC50s of 3.3 and 0.95 nM for BJAB and WSU cell lines in cytotoxicity assay).